Scarica l'app Stockscreener
1.74
60.90%
-2.71
Dopo l'orario di chiusura:
1.71
-0.03
-1.72%
Precedente Chiudi:
$4.45
Aprire:
$1.74
Volume 24 ore:
6.74M
Relative Volume:
69.83
Capitalizzazione di mercato:
$160.43K
Reddito:
$8.77M
Utile/perdita netta:
$-19.05M
Rapporto P/E:
-0.000775
EPS:
-2243.7675
Flusso di cassa netto:
$-11.60M
1 W Prestazione:
-15.12%
1M Prestazione:
-42.95%
6M Prestazione:
-98.68%
1 anno Prestazione:
-99.48%
Intervallo 1D:
$1.61
$1.93
Intervallo di 1 settimana:
$1.61
$6.3999
Portata 52W:
$1.61
$336.00
Nuwellis Inc Stock (NUWE) Company Profile
Nome
Nuwellis Inc
Settore
Industria
Telefono
952-345-4200
Indirizzo
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.74 | 183.48K | 8.77M | -19.05M | -11.60M | -2,243.77 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | ROTH MKM | Buy |
Nuwellis Inc Borsa (NUWE) Ultime notizie
Nuwellis installs Aquadex systems at Wisconsin pediatric hospital By Investing.com - Investing.com Canada
Nuwellis appoints Mike McCormick CEO effective June 30 - scanx.trade
Nuwellis reports 14% second-quarter revenue growth - grafa.com
Nuwellis, Inc. Provides Unaudited Preliminary Results for Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nuwellis reports 14% revenue growth in Q2 2026, driven by Aquadex platform momentum. - Pluang
Nuwellis Q2 Results: Revenue up 14% YoY, H2 growth hits 20% - scanx.trade
Nuwellis reports 14% revenue growth in second quarter 2026 - Investing.com
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth - The Manila Times
Nuwellis Announces Preliminary Revenue Results For The Second Quarter 2026 Showing Double Digit Growth - TradingView
Nuwellis’ new CEO on building a strong foundation for sustainable value creation - Yahoo Finance
Nuwellis Inc (NUWE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nuwellis, Inc. Revenue Breakdown – NASDAQ:NUWE - TradingView
NUWE|Nuwellis Inc|Price:2.000|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
NUWE|Nuwellis Inc|Price:2.050|Chg%:-0.150 - TradingKey
Nuwellis, Inc. Proposes Reverse Stock Split to Maintain Nasdaq Listing – SEC Form 8-K Filing July 2026 - Minichart
Nuwellis Shareholders Approve Reverse Stock Split Authorization - TipRanks
Nuwellis Inc (NUWE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nuwellis Inc. (NUWE) Rallies 5.26% as Stock Tests Key ResistanceBPI Bull Correction - dars.gov.et
Nuwellis secures new US patent for dual-lumen catheter technology - MSN
NUWE News | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis receives patent for dual lumen catheter technology By Investing.com - Investing.com Nigeria
Nuwellis awarded U.S. patent for Dual Lumen Catheter - TipRanks
Nuwellis wins U.S. patent for a catheter that i... - Pluang
Nuwellis (NUWE) Secures Patent for Innovative Catheter Technology - GuruFocus
Nuwellis receives patent for dual lumen catheter technology - Investing.com
Nuwellis Receives U.S. Patent for Dual Lumen Catheter for Extracorporeal Therapies - Quiver Quantitative
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies - The Manila Times
Nuwellis Catheter Design Lets Clinicians Trim Length for Patients - Stock Titan
NUWE Q1 2026 Earnings: Significant EPS Miss Amidst Stock Price IncreaseEarnings Beat Alert - dars.gov.et
Nuwellis names Mike McCormick as CEO - MSN
NUWE Q1 2026 Earnings: Deep EPS Miss Triggers Sharp Stock DeclineEarnings Revision Report - dars.gov.et
NUWE Q1 2026 Earnings: Massive EPS Miss as Company Reports No RevenueNegative Surprise Momentum - dars.gov.et
Form DEF 14A Nuwellis Inc For: 7 July By Investing.com - Investing.com Nigeria
Nuwellis (NASDAQ: NUWE) seeks warrant share and reverse split votes - Stock Titan
Nuwellis to showcase Aquadex therapy at KidneyB... - Pluang
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 - The Manila Times
Nuwellis takes Aquadex to a pediatric kidney conference in Colorado - Stock Titan
Nuwellis Inc. (NUWE) Bounces From Support, Testing Resistance After 5.4% GainOption Breadth - dars.gov.et
NUWE Q1 2026 Earnings: Significant EPS Miss Highlights Persistent Cost PressuresBuyback Announcement Report - dars.gov.et
NUWENuwellis Inc Short Interest - Finviz
Nuwellis (NASDAQ: NUWE) CEO McCormick files initial insider Form 3 - Stock Titan
NUWE Q1 2026 Earnings: EPS Miss of 104.9% Sends Shares LowerNext Quarter Guidance - dars.gov.et
Nuwellis Inc (FRA:22S1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CHF Solutions, Inc.Special Call Transcript - GuruFocus
Nuwellis Inc (FRA:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Revenue per share of Nuwellis, Inc. – FWB:22S1 - TradingView
Price to cash flow ratio of Nuwellis, Inc. – FWB:22S1 - TradingView
Average basic shares outstanding of Nuwellis, Inc. – FWB:22S1 - TradingView
Net income of Nuwellis, Inc. – FWB:22S1 - TradingView
NUWELL.INC.NEW26 DL-,0001 Financial Statements – FWB:22S1 - TradingView
Nuwellis Inc Azioni (NUWE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):